BillionToOne sells genetic blood tests for prenatal screening and cancer care to doctors and clinics. It last closed at $97.50 on Nov 17, up 1.24% on the day. BLLN last reported earnings on Tue, Oct 6, 2026. The average 12-month price target from 4 analysts is $128.25 (+31.5% from the last close), with a high of $135.00 and a low of $120.00. Analyst consensus is Strong Buy, based on the latest ratings from 4 firms (4 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in BLLN, 100% of them bullish and 0% bearish.
Each firm's latest rating on BLLN in the past 90 days
Average 12-month target
$128.25
▲ 31.5% upside
Based on 4 analysts who set a price target on BLLN in the past 90 days. The average target is $128.25, with a high of $135.00 and a low of $120.00, compared with the last close of $97.50.
Low $120.00Avg $128.25High $135.00
Blue marker: last close $97.50
Highest target$135.00
Average target$128.25
Lowest target$120.00
Latest rating changes
Piper SandlerMaintained
Nov 10Buy$130
JP MorganTarget raised
Nov 5Buy$130 → $135
GuggenheimTarget raised
Oct 1Buy$125 → $128
Canaccord GenuityInitiated
Sep 2Buy$120
JP MorganMaintained
Aug 6Buy$130
Date
Firm
Action
Rating
Price target
Nov 10
Piper Sandler
Maintained
Buy
$130
Nov 5
JP Morgan
Target raised
Buy
$130 → $135
Oct 1
Guggenheim
Target raised
Buy
$125 → $128
Sep 2
Canaccord Genuity
Initiated
Buy
$120
Aug 6
JP Morgan
Maintained
Buy
$130
Loading…
Technical Analysis
BLLN · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend, nearing oversold
The stock is 12% below its 20 day and 10% below its 50 day average. It is sitting right on its 200 day average, a level many traders watch. Momentum is weak (RSI 36), near oversold. The nearest support is the Pivot at $97.20, and the nearest resistance the 200 day average at $97.79.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 6.8%/day
Key levels
$150.4452 week high+54.3%
$110.14100 day average+13.0%
$109.6920 day average+12.5%
$106.9050 day average+9.6%
$100.30Pivot R1+2.9%
$100.00Swing high (May 29)+2.6%
$97.79200 day average+0.3%
$97.50Last close
$97.20Pivot−0.3%
$95.23Swing low (Sep 11)−2.3%
$94.41Pivot S1−3.2%
$61.9652 week low−36.5%
Indicators
RSI (14)
36.46
Weak, oversold below 30
Neutral
MACD
-0.77
Below its signal line
Bearish
Stochastic
15.5
Near the bottom of its range
Oversold
ADX (14)
17.0
No clear trend
Williams %R
-85.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-213.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−11.7%
Change over 10 sessions
Bearish
ATR (14)
$6.65
Typical daily range, 6.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling
Short trendBearish
Long trendNot enough history
MomentumFading
StretchNormal
VolatilityNormal, 16.0%/day
Key levels
$150.4452 week high+54.3%
$110.14100 day average+13.0%
$109.6920 day average+12.5%
$106.9050 day average+9.6%
$100.30Pivot R1+2.9%
$100.00Swing high (May 29)+2.6%
$97.79200 day average+0.3%
$97.50Last close
$97.20Pivot−0.3%
$95.23Swing low (Sep 11)−2.3%
$94.41Pivot S1−3.2%
$61.9652 week low−36.5%
Indicators
RSI (14)
46.73
Middle of its range
Neutral
MACD
1.27
Below its signal line
Bearish
Stochastic
36.3
Middle of its range
Neutral
ADX (14)
19.8
No clear trend
Williams %R
-76.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
-65.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−1.3%
Change over 10 sessions
Bearish
ATR (14)
$15.56
Typical daily range, 16.0% of price
MA 10Below
MA 20Below
MA 50Above
MA 100–
MA 200–
What happened before, for BLLN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how BLLN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options Flow
90D
No whale options trades in BLLN in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BLLN is in one of them and how their past BLLN trades turned out.
BillionToOne is a molecular diagnostics company based in Menlo Park, California. It offers genetic tests that analyze cell free DNA from a blood sample, using a sequencing method that counts individual DNA molecules. Its prenatal test, UNITY, assesses fetal genetic risk from a single maternal blood draw. Its Northstar tests are cancer tests used by oncology providers to help select treatments and track how patients respond to therapy.